False-positive levorphanol (opioid) due to dextromethorphan on urine drug screen by time-of-flight MS

Patricia M. Jones, Khushbu Patel

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

A case of a false-positive levorphanol on an LC-QTOF urine drug screen due to the presence of dextromethorphan is described. Levorphanol is a stereoisomer of dextrorphan, the main metabolite of dextromethorphan. Dextromethorphan does not produce the same analgesic and sedative effects as opioids, which exhibit nervous system and respiratory depression. LC-MS assays are not able to distinguish between stereoisomers, and thus dextrorphan in the sample will be recognized as levorphanol. Only enantiomeric chiral LC-MS/MS analysis can help differentiate the two compounds. The primary caregiver was notified that with dextromethorphan present, the detected levorphanol was most likely the metabolite dextrorphan.

Original languageEnglish (US)
Title of host publicationToxicology Cases for the Clinical and Forensic Laboratory
PublisherElsevier
Pages497-499
Number of pages3
ISBN (Electronic)9780128158463
ISBN (Print)9780128163733
DOIs
StatePublished - Jan 1 2020

Keywords

  • LC/Q-TOF mass spectrometry
  • Levorphanol
  • dextromethorphan
  • opioid

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'False-positive levorphanol (opioid) due to dextromethorphan on urine drug screen by time-of-flight MS'. Together they form a unique fingerprint.

Cite this